Stock Market Today, Feb: ImmunityBio Up on Anktiva EU OK
ImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
This piece explains glide path withdrawal strategies for index funds, focusing on steady income while managing sequence of returns risk.
25,847 articlesImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
USA Rare Earth's stock sprinted higher even as broader markets slipped. A major asset deal and clear production miles...
Investors are watching Modine for clues on growth in HVAC and thermal solutions. This guide breaks down the modine (m...
A new class-action alleges that Anthropic overstated Claude Max usage limits and the promised savings. The case could...
Bitcoin trades near $62,000 as macro risks surge. A little-known BTC-Gold ratio signal is flashing, potentially forec...
Reliance Industries sits at the center of India’s growth story. This guide breaks down reliance (rs) 2025 earnings ex...
The battle between FedEx and UPS isn't just about packages—it's about dollars, margins, and future growth. This artic...
A hidden wrinkle in Social Security planning could shake up your retirement budget. This article breaks down what to ...
In 2026, the smartest real estate moves often happen off the public radar. This playbook reveals practical, repeatabl...
SCPQ rose sharply as SpaceX slipped to fresh lows, underscoring daily-reset risks in leveraged inverse ETFs and the m...
Kratos Defense stock just surged after two new contract wins. This article breaks down what happened, why it matters,...
With mortgage rates persistent and prices high, real estate agents helping first-time buyers chart practical loan pat...